Randomized controlled trial of early regular egg intake to prevent egg allergy
- PMID: 27554812
- DOI: 10.1016/j.jaci.2016.06.052
Randomized controlled trial of early regular egg intake to prevent egg allergy
Abstract
Background: The ideal age to introduce egg into the infant diet has been debated for the past 2 decades in the context of rising rates of egg allergy.
Objective: We sought to determine whether regular consumption of egg protein from age 4 to 6 months reduces the risk of IgE-mediated egg allergy in infants with hereditary risk, but without eczema.
Methods: Infants aged 4 to 6 months were randomly allocated to receive daily pasteurized raw whole egg powder (n = 407) or a color-matched rice powder (n = 413) to age 10 months. All infants followed an egg-free diet and cooked egg was introduced to both groups at age 10 months. The primary outcome was IgE-mediated egg allergy defined by a positive pasteurized raw egg challenge and egg sensitization at age 12 months.
Results: There was no difference between groups in the percentage of infants with IgE-mediated egg allergy (egg 7.0% vs control 10.3%; adjusted relative risk, 0.75; 95% CI, 0.48-1.17; P = .20). A higher proportion of participants in the egg group stopped taking the study powder because of a confirmed allergic reaction (25 of 407 [6.1%] compared with 6 of 413 [1.5%]). Egg-specific IgG4 levels were substantially higher in the egg group at 12 months (median, 1.22 mgA/L vs control 0.07 mgA/L; P < .0001).
Conclusions: We found no evidence that regular egg intake from age 4 to 6 months substantially alters the risk of egg allergy by age 1 year in infants who are at hereditary risk of allergic disease and had no eczema symptoms at study entry.
Keywords: Allergy prevention; complementary feeding; egg; food allergy; hereditary risk; oral tolerance; randomized controlled trial.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Comment in
-
Timing of regular egg intake for prevention of egg allergy.J Allergy Clin Immunol. 2018 Jan;141(1):459-460. doi: 10.1016/j.jaci.2017.09.017. Epub 2017 Nov 14. J Allergy Clin Immunol. 2018. PMID: 29146009 No abstract available.
-
Reply.J Allergy Clin Immunol. 2018 Jan;141(1):460-461. doi: 10.1016/j.jaci.2017.09.021. Epub 2017 Nov 14. J Allergy Clin Immunol. 2018. PMID: 29146011 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous